Brief DMT trips linked to lasting improvements in quality of life for depressed patients, with stronger mystical effects predicting better outcomes

DMT treatment for major depressive disorder was linked to sustained improvements in patients' quality of life, even though the acute psychedelic experience lasted only minutes. The strongest gains appeared in emotional well-being, daily functioning, and overall life satisfaction, and people who reported more intense mystical-type effects tended to improve more. The findings come from a clinical study of depressed patients who received DMT in a therapeutic setting and were followed after dosing. Researchers connected short-duration psychedelic sessions with benefits that extended well beyond the drug's immediate effects, adding to evidence that brief but intense altered states can produce meaningful psychological change. DMT stands out because its rapid onset and short action could make psychedelic therapy more scalable than treatments requiring many hours of supervision. The results also support the idea that the subjective quality of the experience, not just drug exposure, may shape antidepressant outcomes.